Clin2
NCT06765603Possibly a fitNot yet recruiting

Combination contact lens and atropine for myopia control in children

Myopia

Part of Eyes & vision clinical trials.

This trial tests a special contact lens combined with atropine eye drops to see if they work better together to slow down worsening nearsightedness (myopia) in children. It might be a good option if your child's eyes are getting more nearsighted and they haven't tried other treatments yet.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
180 people
Ages
7 years to 13 years
Study type
Interventional

Who can take part

  • Your child must be between 7 and 12 years old.
  • Their nearsightedness must be mild to moderate (between -0.75 and -4.50 diopters).
  • They must have little or no astigmatism (less than 1.12 diopters of cylinder).
  • They must have healthy eyes with no need for eye medications or infections.
  • They cannot have used any prior myopia control treatments or been in a myopia study before.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06523504Recruiting· Phase 1/Phase 2
Atropine Drops with Special Glasses for Myopia in Children

This trial tests whether a combination of low-dose atropine eye drops (0.02% or 0.04%) and special glasses (called DIMS) can slow down the worsening of moderate to high myopia in children aged 6 to 12.

Tianjin, Tianjin Municipality
NCT06708156Recruiting· Phase 3
Low-dose atropine drops to slow childhood nearsightedness

This trial tests two low-dose atropine eye drops (0.01% and 0.02%) to see if they can safely slow down the worsening of nearsightedness (myopia) in children. Your child would receive either one of these drops or a placebo (an inactive drop) once daily for up to 2 years.

Hefei, Anhui
NCT07567040Recruiting· Phase 3
Delaying Nearsightedness Onset in Children

This study tests whether low-dose atropine eye drops can prevent or slow down nearsightedness in children ages 6–11 who don't yet need glasses. The goal is to keep children's vision stable and reduce their need for corrective lenses as they grow.

Birmingham, Alabama
NCT07028827Recruiting· Phase 3
Atropine eye drops for nearsightedness in kids and teens

This trial tests whether atropine eye drops can slow down worsening nearsightedness (myopia) in children and teenagers. It may help keep their eyesight from getting worse over time.

Tirana
NCT07164092Not yet recruiting· Phase 2/Phase 3
Atropine drops for slowing nearsightedness in children

This study tests whether atropine eye drops can slow down worsening nearsightedness in children. It is for children whose nearsightedness is getting worse quickly and who have not tried other treatments.

NCT07176949Recruiting
Early myopia prevention study for young children

This study tests a program to prevent or slow down early nearsightedness (myopia) in children ages 3 to 6. It aims to find out if certain eye care methods can help keep their vision healthy.

Shanghai, Shanghai Municipality

Hear when a new Myopia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.